Fulcrum Therapeutics (FULC) Other financing activities (2019 - 2026)

Fulcrum Therapeutics (FULC) reported Other financing activities of $333000.0 for Q1 2026, up 879.41% quarter-over-quarter from $34000.0 in Q1 2019.

Fulcrum Therapeutics (FULC) Other financing activities (2019 - 2026) Analysis & Trends

Fulcrum Therapeutics (FULC) has 2 years of Other financing activities data on file, last reported at $333000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn
9	Abivax	91.71 Bn	91.71 Bn	-
10	Fulcrum Therapeutics	267.90 Mn	267.90 Mn	-

Download Data